FIGURE

Fig. 4

ID

ZDB-FIG-250207-59

Publication

Della Vecchia et al., 2025 - Dapagliflozin ameliorates Lafora disease phenotype in a zebrafish model

Other Figures

All Figure Page

Back to All Figure Page

Fig. 4

(A) qRT-PCR analysis of the autophagy-lysosomal pathway. Three independent experiments were performed per experimental group (WT controls, and epm2a^−/− and DAPA-treated epm2a^−/− larvae). Statistical analysis was performed using the ANOVA test. The values are expressed as mean ± standard error of the mean (SEM). (B) Three independent larval homogenates, from controls (n = 50), epm2a^−/− larvae (n = 50) and DAPA-treated epm2a^−/− larvae (n = 50), were tested by Western blotting for the expression of LC3 protein. The protein levels were normalized to GAPDH. Statistical analysis was performed using the ANOVA test. The values are expressed as mean ± SEM. (**** p ≤ 0.0001; ***p ≤ 0.001; **p ≤ 0.01; *p ≤ 0.05).

Expression Data

Genes:	atg5 atg12 becn1 map1lc3a mtor sqstm1 tfeb
Fish:	AB epm2a^{zf3794/zf3794} (AB)
Condition:	chemical treatment by environment: dapagliflozin
Anatomical Term:	whole organism
Stage:	Day 5

Expression Detail

Antibody Labeling

Phenotype Data

Fish:	epm2a^{zf3794/zf3794} (AB)
Condition:	chemical treatment by environment: dapagliflozin
Observed In:	whole organism
Stage:	Day 5

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Biomed. Pharmacother.